# A Tetrad Catastrophe: Paraneoplastic Syndrome With Abducens Palsy, Intracranial Hypertension, and Optic Neuropathy in Primary Lung Cancer

**Authors:** Venushia Chandran, Nurul Ain Masnon, Rona A Nasaruddin, Jemaima Che Hamzah, Adzleen Mohmood, Andik Fadilah Abdul Aziz

PMC · DOI: 10.7759/cureus.67335 · 2024-08-20

## TL;DR

A rare case of paraneoplastic syndrome in lung cancer caused vision loss and nerve issues, highlighting the difficulty in diagnosing and treating such conditions.

## Contribution

This paper presents a unique clinical case linking paraneoplastic syndrome with abducens palsy, intracranial hypertension, and optic neuropathy in lung cancer.

## Key findings

- The patient's symptoms resolved partially with treatment but ultimately died within six months.
- Anti-Hu and anti-CV2 antibodies were detected, indicating an autoimmune component.
- Neuroimaging was normal, emphasizing the diagnostic challenge of paraneoplastic syndromes.

## Abstract

We report a unique case of paraneoplastic syndrome (PS) associated with primary lung cancer. A 57-year-old woman experienced headaches and bilateral visual loss one month after the onset of isolated right abducens palsy. Examination revealed bilateral poor visual acuity (VA), papilledema, and persistent right abducens palsy. Neuroimaging was normal. Lumbar puncture revealed high cerebrospinal fluid (CSF) opening pressure and protein levels. She was started on acetazolamide and pulse methylprednisolone followed by oral corticosteroids. Her abducens nerve palsy resolved, but her VA deteriorated. Anti-Hu and anti-CV2 were positive. A positron emission tomography (PET) scan revealed primary lung cancer, and she died six months after her initial presentation. This case demonstrated that PS poses a diagnostic challenge and may be associated with poor prognosis.

## Linked entities

- **Chemicals:** acetazolamide (PubChem CID 1986), methylprednisolone (PubChem CID 6741)
- **Diseases:** paraneoplastic syndrome (MONDO:0021073), lung cancer (MONDO:0005138), intracranial hypertension (MONDO:0006810)

## Full-text entities

- **Genes:** BMPER (BMP binding endothelial regulator) [NCBI Gene 168667] {aka CRIM3, CV-2, CV2}
- **Diseases:** papilledema (MESH:D010211), Primary Lung Cancer (MESH:D008175), Tetrad Catastrophe (MESH:D002388), Optic Neuropathy (MESH:D009901), Abducens Palsy (MESH:D020434), PS (MESH:D010257), Intracranial Hypertension (MESH:D019586), visual loss (MESH:D014786), headaches (MESH:D006261)
- **Chemicals:** acetazolamide (MESH:D000086), methylprednisolone (MESH:D008775)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11412775/full.md

---
Source: https://tomesphere.com/paper/PMC11412775